• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肝脏再生早期阶段的胆汁盐与成纤维细胞生长因子19信号传导

Bile Salt and FGF19 Signaling in the Early Phase of Human Liver Regeneration.

作者信息

Koelfat Kiran V K, van Mierlo Kim M C, Lodewick Toine M, Bloemen Johanne G, van der Kroft Gregory, Amygdalos Iakovos, Neumann Ulf P, Dejong Cornelis H C, Jansen Peter L M, Olde Damink Steven W M, Schaap Frank G

机构信息

Department of SurgeryNUTRIM School of Nutrition and Translational Research in MetabolismMaastricht UniversityMaastrichtThe Netherlands.

Department of RadiologyMaastricht University Medical Center+MaastrichtThe Netherlands.

出版信息

Hepatol Commun. 2021 May 5;5(8):1400-1411. doi: 10.1002/hep4.1728. eCollection 2021 Aug.

DOI:10.1002/hep4.1728
PMID:34430784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8369949/
Abstract

The involvement of bile salt-fibroblast growth factor 19 (FGF19) signaling in human liver regeneration (LR) is not well studied. Therefore, we studied aspects of bile salt-FGF19 signaling shortly after liver resection in patients. We compared plasma bile salt and FGF19 levels in arterial, portal and hepatic venous blood, calculated venous-arterial differences (ΔVA), and determined hepatic transcript levels on two intra-operative time points: before (< 1 hour) and immediately after (> 2-3 hours) liver resection (i.e., following surgery). Postoperative bile salt and FGF19 levels were assessed on days 1, 2, and 3. LR was studied by computed tomography (CT)-liver volumetry. Following surgery, the liver, arterial, and portal bile salt levels were elevated ( < 0.05). Furthermore, an increased amount of bile salts was released in portal blood and extracted by the remnant liver ( < 0.05). Postoperatively, bile salt levels were elevated from day 1 onward ( < 0.001). For FGF19, intra-operative or postoperative changes of ΔVA or plasma levels were not observed. The bile salt-homeostatic regulator farnesoid X receptor () was markedly up-regulated following surgery ( < 0.001). Cell-cycle re-entry priming factors (interleukin 6 [], signal transducer and activator of transcription 3 [], and ) were up-regulated following surgery and were positively correlated with expression  < 0.05). Postoperative hyperbilirubinemia was preceded by postsurgery low and high Na+/Taurocholate cotransporting polypeptide () expression in the remnant liver coupled with higher liver bile salt content ( < 0.05). Finally, bile salt levels on postoperative day 1 were an independent predictor of LR ( < 0.05). : Systemic, portal, and liver bile salt levels are rapidly elevated after liver resection. Postoperative bile salts were positively associated with liver volume gain. In the studied time frame, FGF19 levels remained unaltered, suggesting that FGF19 plays a minor role in human LR. These findings indicate a more relevant role of bile salts in human LR.

摘要

胆汁盐-成纤维细胞生长因子19(FGF19)信号通路在人类肝脏再生(LR)中的作用尚未得到充分研究。因此,我们对肝切除术后患者短期内的胆汁盐-FGF19信号通路进行了研究。我们比较了动脉血、门静脉血和肝静脉血中的血浆胆汁盐和FGF19水平,计算了动静脉差值(ΔVA),并在两个手术时间点测定了肝脏转录水平:肝切除术前(<1小时)和肝切除术后立即(>2-3小时)(即手术后)。在术后第1、2和3天评估术后胆汁盐和FGF19水平。通过计算机断层扫描(CT)肝脏容积测量法研究肝脏再生。手术后,肝脏、动脉和门静脉胆汁盐水平升高(<0.05)。此外,门静脉血中释放的胆汁盐量增加,并被残余肝脏摄取(<0.05)。术后,胆汁盐水平从第1天开始升高(<0.001)。对于FGF19,未观察到术中或术后ΔVA或血浆水平的变化。胆汁盐稳态调节因子法尼醇X受体()在手术后显著上调(<0.001)。细胞周期重新进入启动因子(白细胞介素6 []、信号转导和转录激活因子3 []以及)在手术后上调,且与表达呈正相关(<0.05)。术后高胆红素血症之前,残余肝脏中手术后低和高钠/牛磺胆酸盐共转运多肽()表达以及肝脏胆汁盐含量较高(<0.05)。最后,术后第1天的胆汁盐水平是肝脏再生的独立预测因子(<0.05)。结论:肝切除术后全身、门静脉和肝脏胆汁盐水平迅速升高。术后胆汁盐与肝脏体积增加呈正相关。在研究的时间范围内,FGF19水平保持不变,表明FGF19在人类肝脏再生中起次要作用。这些发现表明胆汁盐在人类肝脏再生中具有更重要的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/a48e13154935/HEP4-5-1400-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/92044218853a/HEP4-5-1400-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/58d6791525db/HEP4-5-1400-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/74ea6b58bab8/HEP4-5-1400-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/a48e13154935/HEP4-5-1400-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/92044218853a/HEP4-5-1400-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/58d6791525db/HEP4-5-1400-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/74ea6b58bab8/HEP4-5-1400-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d77/8369949/a48e13154935/HEP4-5-1400-g004.jpg

相似文献

1
Bile Salt and FGF19 Signaling in the Early Phase of Human Liver Regeneration.人类肝脏再生早期阶段的胆汁盐与成纤维细胞生长因子19信号传导
Hepatol Commun. 2021 May 5;5(8):1400-1411. doi: 10.1002/hep4.1728. eCollection 2021 Aug.
2
Partial liver resection alters the bile salt-FGF19 axis in patients with perihilar cholangiocarcinoma: Implications for liver regeneration.部分肝切除术改变了肝门部胆管癌患者的胆盐-FGF19 轴:对肝脏再生的影响。
Hepatol Commun. 2024 Jun 5;8(6). doi: 10.1097/HC9.0000000000000445. eCollection 2024 Jun 1.
3
The portal-drained viscera release fibroblast growth factor 19 in humans.门脉引流的内脏在人体中释放成纤维细胞生长因子19。
Physiol Rep. 2016 Dec;4(24). doi: 10.14814/phy2.13037.
4
The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.人类胆囊将成纤维细胞生长因子 19 分泌到胆汁中:探索成纤维细胞生长因子 19 在肠胆通路中的作用。
Hepatology. 2012 Feb;55(2):575-83. doi: 10.1002/hep.24702. Epub 2011 Dec 19.
5
Chyme Reinfusion Restores the Regulatory Bile Salt-FGF19 Axis in Patients With Intestinal Failure.肠液回输可恢复肠衰竭患者的调节性胆汁盐-FGF19 轴。
Hepatology. 2021 Nov;74(5):2670-2683. doi: 10.1002/hep.32017. Epub 2021 Aug 26.
6
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.原发性硬化性胆管炎患者口服鹅去氧胆酸激发试验后成纤维细胞生长因子19的延长反应
Hepatol Int. 2017 Jan;11(1):132-140. doi: 10.1007/s12072-016-9769-7. Epub 2016 Sep 30.
7
Circulating Fibroblast Growth Factor 19 in Portal and Systemic Blood.门静脉血和全身血中循环的成纤维细胞生长因子19
J Clin Exp Hepatol. 2018 Jun;8(2):162-168. doi: 10.1016/j.jceh.2017.07.001. Epub 2017 Jul 28.
8
Tissue-specific mechanisms of bile acid homeostasis and activation of FXR-FGF19 signaling in preterm and term neonatal pigs.胆汁酸稳态的组织特异性机制及 FXR-FGF19 信号在早产和足月新生仔猪中的激活
Am J Physiol Gastrointest Liver Physiol. 2022 Jan 1;322(1):G117-G133. doi: 10.1152/ajpgi.00274.2021. Epub 2021 Dec 1.
9
Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding.腹腔镜胃束带术后胆汁酸谱、GLP-1 和 FGF19 的动态变化。
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2974-2984. doi: 10.1210/jc.2017-00235.
10
High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.胆汁盐稳态激素成纤维细胞生长因子19在肝外胆汁淤积患者肝脏中的高表达。
Hepatology. 2009 Apr;49(4):1228-35. doi: 10.1002/hep.22771.

引用本文的文献

1
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.肝脏修复与再生的分子机制:从生理学到治疗学
Signal Transduct Target Ther. 2025 Feb 8;10(1):63. doi: 10.1038/s41392-024-02104-8.
2
The significance of severe postoperative complications on liver regeneration.严重术后并发症对肝再生的意义。
Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):978-980. doi: 10.21037/hbsn-23-487. Epub 2023 Nov 13.
3
Current evidence on posthepatectomy liver failure: comprehensive review.当前关于肝切除术后肝功能衰竭的证据:全面综述。
BJS Open. 2022 Nov 2;6(6). doi: 10.1093/bjsopen/zrac142.
4
Critical Overview of Hepatic Factors That Link Non-Alcoholic Fatty Liver Disease and Acute Kidney Injury: Physiology and Therapeutic Implications.非酒精性脂肪性肝病与急性肾损伤相关的肝脏因素的批判性综述:生理学和治疗意义。
Int J Mol Sci. 2022 Oct 18;23(20):12464. doi: 10.3390/ijms232012464.
5
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions.多能干细胞衍生的治疗急性肝衰竭策略:现状与未来方向。
J Clin Transl Hepatol. 2022 Aug 28;10(4):692-699. doi: 10.14218/JCTH.2021.00353. Epub 2022 Mar 9.
6
Fibroblast growth factor 15/19 expression, regulation, and function: An overview.成纤维细胞生长因子 15/19 的表达、调控与功能:概述。
Mol Cell Endocrinol. 2022 May 15;548:111617. doi: 10.1016/j.mce.2022.111617. Epub 2022 Mar 15.